Medical Advisor | Endoluminal Solutions

Graduated from Tohoku University School of Medicine in 1988, Doctor of Medicine.
After working in the Department of Internal Medicine at Tohoku Rosai Hospital, the Third Department of Internal Medicine at Tohoku University School of Medicine, the Department of Pathology at Tohoku University Hospital, and studying abroad at the National Cancer Institute in the United States, he joined the Cancer Screening Center of the Miyagi Cancer Association in 2004, and has been serving as the Director of the Cancer Screening Center and Executive Director of the Miyagi Cancer Association since 2020.
He has served as a former director of the Japanese Society of Digestive Cancer Screening, an advisor to the Society's Gastric Cancer Screening Quality Control Committee, chairman of the editorial committee for the revised edition of the Gastric Endoscopic Screening Manual for Preventive Screening, and chairman of the editorial committee for the Gastric X-ray Screening Imaging Method Manual.

-Comments about our products-

Approximately 10 years have passed since gastroscopy screening was introduced as a public cancer prevention measure in Japan. Current gastroscopy screening is mainly conducted as an individual examination within the framework of health insurance treatment, and while it has a high diagnostic accuracy, it also places a heavy burden on local medical care.
As a result, issues such as limited capacity in the testing system, uneven distribution of medical institutions across regions, and high cost structures have become apparent, and there are still regions that are not fully benefiting from this.
The screening-specific disposable endoscopic system being developed by Endoluminal Solutions is expected to be an effective solution to the issues of "mass processing capacity," "accessibility," and "economic efficiency" that have been plaguing conventional endoscopic screening, while maintaining sufficient performance for gastric cancer screening.
If this system is implemented in society, it will be possible to provide highly accurate gastrointestinal endoscopy examinations as an alternative to gastric X-ray examinations (barium tests) even in areas where it has been necessary to rely on mass examinations via mobile buses.
There are high hopes for this system, which will free examinees from the disadvantages of radiation exposure and help create a society in which everyone can receive equal, high-quality stomach cancer screening, regardless of where they live.

Graduated from the Kobe University School of Medicine in 2001 and received his Doctor of Medicine degree in 2012.
He has accumulated clinical experience, primarily in diagnostic radiology and interventional radiology, at Osaka University Hospital and related facilities, and has worked in a wide range of fields, from diagnostic imaging to minimally invasive treatment.
In 2022, he was appointed associate professor of the Endowed Chair in High-Precision Image-Guided Puncture Therapy, focusing on clinical practice, research, and education aimed at improving the precision and safety of image-guided treatment. In 2025, he was appointed deputy director of the Department of Radiology (and director of the IVR Center) at Osaka University Hospital, where he is responsible for medical treatment, education, and research, as well as department management and the development of the next generation of human resources.

-Comments about our products-
I have recently been appointed as a medical advisor for Endoluminal Solutions. As a physician specializing in diagnostic radiology, I have also been involved in medical screening. Because a barium stomach examination uses X-rays, even a single examination is said to expose patients to radiation equivalent to several dozen times that of a chest X-ray. Screening examinations are medical treatments that healthy people undergo repeatedly, and radiation exposure is cumulative. Given that the probability of future effects theoretically increases with cumulative radiation dose, and given that alternative methods that do not use radiation are now being established, it is unavoidable to reconsider the nature of screening.
Endoscopic technology has made great advances over the past few decades and has reached a mature stage in terms of diagnostic accuracy, safety, and operation. I believe that the transition from radiation-dependent screening to more rational and sustainable methods is a natural evolution in medicine. This project is an effort to practically support this transition while also addressing infection control and practical issues. I have decided to participate in this project as a specialist, with an eye toward the next stage of screening medicine.

After working at a management consulting firm, he worked as the head of the reliability assurance department at a medical device industry support organization.
He has extensive experience in GLP testing, biological safety testing, and standard testing of the reliability of application documents. He also has experience and a proven track record in supporting the development of medical devices from class I to IV.
Responsible for quality assurance in all processes, including design, development, manufacturing, sterilization, distribution, and post-market surveillance, in accordance with domestic and international regulations and quality standards.